Tag: Research Excellence in Pharmacy Award

Cem Calışkan | Pharmaceutical Science | Best Researcher Award

Published on by World Science Awards

Dr. Cem Calışkan | Pharmaceutical Science | Best Researcher Award

R&D Manager from World Medicine, Turkey

Dr. Cem Çalışkan is an accomplished R&D Manager and pharmaceutical researcher with a distinguished background in analytical chemistry, method development, and regulatory compliance. His professional journey is marked by extensive contributions to the pharmaceutical industry, particularly in analytical method validation, formulation development, and laboratory accreditation processes. With over a decade of progressive experience, Dr. Çalışkan has held key roles at leading pharmaceutical organizations including World Medicine and Neutec İlaç, consistently driving innovation and excellence in pharmaceutical R&D. His academic background features a Ph.D. in Analytical Chemistry from Yıldız Technical University, complemented by a Master’s degree in Organic Chemistry and ongoing Executive MBA studies at Istanbul University, reflecting a multidisciplinary approach to science and leadership. Dr. Çalışkan’s portfolio includes several peer-reviewed publications in top scientific journals, where he explores themes such as nitrosamine detection, impurity profiling, stability-indicating methods, and in-vitro drug release. His research not only addresses critical analytical challenges but also aligns with global regulatory standards. With a passion for mentoring, scientific rigor, and innovation, Dr. Çalışkan exemplifies the integration of academic excellence and industrial impact, making him a strong candidate for scientific recognition at the international level.

Professional Profile

Education

Dr. Cem Çalışkan has a comprehensive and interdisciplinary educational background that has shaped his expertise in analytical and organic chemistry as well as pharmaceutical development. He earned his Doctor of Philosophy (Ph.D.) in Analytical Chemistry from Yıldız Technical University between 2018 and 2022, where he focused on advanced analytical techniques and pharmaceutical applications. His doctoral work provided the foundation for several high-impact scientific publications and patents in method validation and impurity analysis. To complement his scientific expertise with managerial insight, Dr. Çalışkan is currently pursuing an Executive MBA at Istanbul University (2024–present), focusing on strategic business management and leadership in the pharmaceutical industry. His academic journey also includes a Master of Science in Organic Chemistry from Sakarya University (2014–2016), where he deepened his understanding of chemical reactions, drug formulation, and molecular mechanisms. He holds a Bachelor of Science in Chemistry from Uludağ University (2003–2009), which laid the initial groundwork for his professional path in R&D. This strong academic progression, spanning both the sciences and management, enables Dr. Çalışkan to bridge the gap between innovative research and strategic decision-making in the pharmaceutical sector.

Professional Experience

Dr. Cem Çalışkan’s professional experience reflects a sustained commitment to innovation and quality in pharmaceutical research and development. Since 2020, he has been serving as the R&D Manager at World Medicine, where he leads cross-functional teams in analytical development, method validation, and compliance with international regulatory standards. In this role, he initiated the patented WMINOLAB analytical service model, exemplifying his vision for high-quality, independent R&D frameworks. Prior to this, from February to August 2020, he held the position of R&D Analytical Development Chief at the same organization, coordinating sustainable business process models, documentation systems, and team development initiatives. Between 2013 and 2020, Dr. Çalışkan worked as an R&D Responsible Specialist, playing a critical role in analytical method development, stability testing, and responding to regulatory queries from global authorities. Earlier in his career, he served as a Process Development Analyst at Neutec İlaç (2011–2013), where he conducted formulation trials, transfer validations, and documentation for CTD Module III. These roles have not only honed his technical capabilities but also highlighted his strategic thinking, regulatory insight, and project management skills in both domestic and international pharmaceutical landscapes.

Research Interests

Dr. Cem Çalışkan’s research interests center on pharmaceutical analytical chemistry, with a special focus on developing novel methods for impurity profiling, drug stability studies, and nitrosamine risk assessment. He is deeply engaged in creating robust and regulatory-compliant analytical methodologies using cutting-edge instruments such as LC-MS/MS, RP-HPLC, and FTIR spectroscopy. His scientific inquiries aim to improve the accuracy, reproducibility, and efficiency of pharmaceutical testing methods, ensuring safer and more effective drug formulations. A key area of his work involves validating stability-indicating methods for various drug compounds, exploring the physicochemical behavior of active pharmaceutical ingredients (APIs) and excipients under stress conditions. He is also involved in studies on in-vitro drug release, polymer membrane permeability, and analytical compatibility of formulation components. In recent years, Dr. Çalışkan has broadened his scope to include the assessment of genotoxic impurities and packaging-related contaminant analysis, which are critical in modern pharmaceutical safety regulations. His interest in bridging laboratory innovation with regulatory frameworks is reflected in his leadership of accredited research labs and method development teams. This intersection of research excellence and industry relevance defines his contribution to the evolving landscape of pharmaceutical sciences.

Research Skills

Dr. Cem Çalışkan possesses a broad and advanced skill set in pharmaceutical R&D, particularly in the analytical domain. His technical proficiency includes the use of LC-MS/MS, RP-HPLC, FTIR, UV-Vis spectroscopy, and gravimetric analysis for method development, validation, and impurity determination. He is well-versed in Good Laboratory Practice (GLP) and has led numerous method validation studies, including for high-risk pharmaceutical substances like nitrosamines and complex impurities. His skills extend to process optimization, formulation compatibility testing, and the analytical transfer of drug products across laboratories and regulatory environments. Dr. Çalışkan also excels in scientific documentation, protocol writing, and preparation of CTD Module III files for regulatory submission. Beyond technical expertise, he has notable experience in project management, cross-departmental coordination, and team training, equipping him to lead dynamic research teams. His communication skills support effective regulatory correspondence with ministries and international partners, while his analytical thinking aids in critical decision-making across all stages of pharmaceutical development. Combined, these research skills make him not only a technically sound researcher but also an effective scientific leader.

Awards and Honors

While specific awards and honors are not listed in his current profile, Dr. Cem Çalışkan’s career accomplishments reflect a reputation for research excellence and industrial innovation. His leadership in the development and implementation of WMINOLAB, a patented analytical service platform within World Medicine, stands as a testament to his ability to deliver novel, scalable solutions to industry-wide challenges. His publications in reputable journals such as the Journal of Pharmaceutical Sciences, European Journal of Mass Spectrometry, and Journal of AOAC International showcase his academic influence and contributions to pharmaceutical quality control and safety. Additionally, Dr. Çalışkan has played a crucial role in securing and maintaining laboratory accreditations, further evidencing his standing in the professional R&D community. With continued recognition through publications, cross-functional leadership roles, and innovation in analytical techniques, it is evident that he is well-positioned for formal accolades in both industrial and academic circles. Nomination for a Best Researcher Award would be a fitting acknowledgment of his significant impact on pharmaceutical research and method validation at both national and international levels.

Conclusion

Dr. Cem Çalışkan represents a compelling candidate for the Best Researcher Award, bringing together scientific rigor, innovative thinking, and impactful leadership in the pharmaceutical sector. His multi-tiered education, from chemistry through analytical science to business management, empowers him to operate effectively at the intersection of research, industry, and regulation. His extensive experience with analytical method development, impurity profiling, and compliance documentation, along with his proactive approach to laboratory innovation, positions him as a distinguished researcher. His publication record reinforces his scientific credibility, while his managerial roles highlight his ability to lead R&D initiatives with strategic foresight. What sets Dr. Çalışkan apart is not only his technical excellence but also his drive to elevate pharmaceutical research standards in Turkey and beyond. As the industry faces increasing regulatory scrutiny and demands for innovation, his skill set is more relevant than ever. Recognizing his achievements through a Best Researcher Award would honor a career dedicated to advancing analytical science and fostering pharmaceutical innovation, while inspiring emerging researchers to pursue excellence in both academia and industry.

Publications Top Notes

1. Comparison of permeability of topical Cream drug through polymer synthetic membranes of different structures using Franz Cell diffusion test

  • Authors: Cihan Torlak, Müge Güleli, Şevki Kızılok, Remziye Azra Kartop, et al.

  • Year: 2024

  • Journal: Journal of Dispersion Science and Technology

2. Evaluation of a Novel LC‑MS/MS Based Analytical Method for the Risk Assessment of Nitrosamines in Pharmaceutical Products and Packaging Materials

  • Authors: Remziye Azra Kartop, Cihan Torlak, et al. (study led by Kartop and colleagues)

  • Year: 2024

  • Journal: Journal of Pharmaceutical Sciences

3. Simultaneous quantification of tiotropium bromide impurities G + H in capsule formulation by LC‑MS/MS

  • Authors: Not specified in preview

  • Year: 2023

  • Journal: European Journal of Mass Spectrometry

 

 

Prem Shankar Mishra | Pharmaceutical Science | Best Researcher Award

Published on by World Science Awards

Dr. Prem Shankar Mishra | Pharmaceutical Science | Best Researcher Award

Professor at Galgotias University, India

Dr. Prem Shankar Mishra is a distinguished academician and pharmaceutical scientist currently serving as Associate Professor and Head of the D.Pharm Programme at Galgotias University. With over a decade of experience in teaching, research, and academic administration, he has established himself as a result-oriented educator and innovative researcher in pharmaceutical sciences. His expertise spans drug design, heterocyclic synthesis, molecular docking, anticancer research, and analytical characterization techniques. Dr. Mishra has successfully guided undergraduate and diploma pharmacy students while contributing significantly to curriculum development, accreditation processes, and outcome-based education systems. He has published numerous research articles in reputed international journals and authored book chapters with global publishers. In addition to his academic contributions, he holds multiple granted Indian and international patents in the fields of pharmaceutical formulations, synthetic chemistry, and biomedical devices. His leadership roles in NAAC/NBA accreditation activities and conference organization reflect his administrative competence and commitment to quality education. Dr. Mishra integrates research innovation with academic excellence, promoting interdisciplinary collaboration and fostering a culture of scientific inquiry. His professional journey reflects dedication to advancing pharmaceutical education and impactful drug discovery research.

Professional Profile

Education

Dr. Prem Shankar Mishra possesses a strong and multidisciplinary academic foundation in pharmacy and law. He completed his Ph.D. in Pharmacy from VISTAS in 2021, focusing on the design, synthesis, and evaluation of 2-pyridone derivatives as potential anticancer agents. His doctoral research emphasized drug design, heterocyclic synthesis, molecular docking, and in-vitro anticancer evaluation under expert supervision from NIPER Kolkata leadership. He earned his Master of Pharmacy (M.Pharm) in Pharmaceutical Chemistry from The Tamil Nadu Dr. M.G.R. Medical University in 2010, building strong expertise in synthetic chemistry and analytical techniques. Earlier, he completed his Bachelor of Pharmacy (B.Pharm) from an institution affiliated with Uttar Pradesh Technical University in 2007. Expanding his interdisciplinary knowledge, he also obtained a Bachelor of Laws (LL.B.) degree from Chaudhary Charan Singh University in 2017. His educational background combines pharmaceutical sciences, research methodology, regulatory awareness, and legal understanding, enabling him to contribute effectively to academic leadership, patent development, and regulatory compliance in higher education and pharmaceutical research.

Professional Experience

Dr. Prem Shankar Mishra has more than ten years of comprehensive experience in teaching, research supervision, and academic administration. Since December 2017, he has been serving as Associate Professor in the Department of Pharmacy at Galgotias University, where he also holds the position of Head of the D.Pharm Programme. In this role, he oversees curriculum implementation, faculty coordination, accreditation processes, regulatory compliance with PCI, NAAC, and NBA standards, and academic planning aligned with outcome-based education under the Washington Accord framework. Prior to this, he worked as Assistant Professor at Meerut Institute of Engineering and Technology from 2010 to 2017, contributing to undergraduate and postgraduate pharmacy education. He also gained early teaching experience as a guest lecturer at Government Polytechnic College, Lakhimpur Kheri. Beyond classroom teaching, Dr. Mishra has organized international conferences, participated in faculty development programs, and served as an external examiner for pharmacy institutions. His professional journey reflects consistent academic growth, leadership in quality assurance initiatives, student mentorship, and active engagement in research-driven pharmaceutical education and institutional development.

Research Interests

Dr. Prem Shankar Mishra’s research interests are centered on pharmaceutical chemistry with a strong emphasis on anticancer drug discovery and development. His primary focus includes the design, synthesis, and characterization of heterocyclic compounds, particularly 2-pyridone and pyridazine derivatives, for potential therapeutic applications. He actively integrates in-silico molecular docking studies with wet-lab synthesis and biological evaluation to accelerate rational drug design. His expertise extends to cell culture-based assays such as MTT assays, flow cytometry (FACS), cell cycle analysis, and reactive oxygen species studies for evaluating cytotoxic effects. Dr. Mishra is also interested in green synthesis approaches, nano-formulations, transdermal delivery systems, and advanced analytical techniques including IR, NMR, HPLC, and UV spectroscopy. He has contributed to computational drug discovery, deep learning applications in site-specific drug delivery, and immunotherapy-based strategies targeting skin cancer. His interdisciplinary research approach bridges synthetic organic chemistry, computational modeling, pharmacological screening, and formulation science. Through funded proposals and patented innovations, he continues to explore novel bioactive molecules and advanced drug delivery systems aimed at improving therapeutic efficacy and safety.

Awards and Honors

Dr. Prem Shankar Mishra has received notable recognition for his academic and research contributions in pharmaceutical sciences. He has secured multiple granted Indian and international patents, including innovations in nanoemulgel formulations, pyridazine derivatives, antimicrobial devices, and transdermal drug delivery systems. His research initiatives have attracted funding support, including a grant from DRDO for organizing a national conference, reflecting institutional trust in his academic leadership. He has actively participated in national and international conferences, winning awards such as first prize in oral presentation during National Pharmacy Week. Dr. Mishra has completed several prestigious NPTEL-AICTE and AICTE-ATAL sponsored faculty development programs focusing on accreditation, patent creation, outcome-based education, and innovative pedagogy. His involvement as a core team member in NAAC/NBA accreditation processes highlights his commitment to maintaining academic quality standards. Additionally, he has served as an external examiner and evaluator for pharmacy institutions. These achievements demonstrate his dedication to academic excellence, research innovation, patent development, professional training, and continuous professional growth in pharmaceutical education and drug discovery research.

Conclusion

Dr. Prem Shankar Mishra exemplifies a balanced integration of academic excellence, innovative research, and effective leadership in pharmaceutical sciences. With strong qualifications in pharmacy and law, extensive teaching experience, and active engagement in drug discovery research, he has made meaningful contributions to anticancer therapeutics, molecular modeling, and pharmaceutical formulation development. His granted patents and funded research proposals reflect his commitment to translational research and practical innovation. As an academic leader at Galgotias University, he plays a vital role in curriculum development, accreditation processes, and outcome-based education implementation. His ability to combine computational drug design, synthetic chemistry, biological evaluation, and regulatory understanding demonstrates interdisciplinary strength. Through mentorship, research publications, conference organization, and policy contributions, he continues to foster scientific inquiry and academic quality. Dr. Mishra’s career trajectory highlights sustained dedication to advancing pharmaceutical education, strengthening research culture, and contributing to impactful drug development strategies aimed at addressing critical healthcare challenges.

Publication Top Noted

  1. Natural Metabolites as Modulators of Sensing and Signaling Mechanisms: Unlocking Anti-Ovarian Cancer Potential
    Year: 2025
    📝 Contributors: Megha Verma, Prem Shankar Mishra, S.K. Abdul Rahaman, Tanya Gupta, Abid Ali Sheikh, Ashok Kumar Sah, and international collaborators
    📚 Journal: Biomedicines
    📌 Type: Review • Open Access
    📊 Citations: 1
  2. Implementation of QKD-Based System Using Nano PCF for Healthcare Applications
    Year: 2025
    Contributors: A.K. Vyas, A. Dixit, S. Tiwari, Prem Shankar Mishra, D.K. Gupta, S. Srivastava, V. Singh
    Journal: Sensing and Bio-Sensing Research
  3. AI-Assisted Immunology for Precision Cancer Medicine
    Year: 2025
    Contributors: Ashok Kumar Sah, Megha Verma, Prem Shankar Mishra, S.K. Abdul Rahaman, Tanya Gupta, and co-authors
    Citations: 1

Bashige Chiribagula Valentin | Pharmaceutical Science | Best Researcher Award

Published on by World Science Awards

Prof. Bashige Chiribagula Valentin | Pharmaceutical Science | Best Researcher Award

Professor of UNILU, Congo.

Dr. Bashige Chiribagula Valentin is a prominent academic and researcher specializing in ethnopharmacology, medicinal chemistry, and quality control. Currently a professor at the University of Lubumbashi, he has held roles including department head, research specialist in pharmacognosy, and educator in pharmacology. His research focuses on the ethnobotanical, phytochemical, and pharmacological properties of medicinal plants, with significant contributions to the development of traditional medicine-based therapies, such as antimalarial and antimicrobial agents. Dr. Chiribagula has led various projects aimed at enhancing the quality and efficacy of herbal remedies and has published extensively in reputed journals. His work includes studies on plant-based treatments for malaria, diabetes, and wound healing, reflecting his commitment to integrating traditional knowledge with modern scientific approaches. His leadership in the academic and scientific community, coupled with his impactful research, underscores his candidacy for the Best Researcher Award.

Profile
Education

Dr. Bashige Chiribagula Valentin’s educational background is extensive and well-rounded. He earned his Doctorate in Pharmaceutical Sciences from the University of Lubumbashi (UNILU) and the Université de Mons (UMONS) in 2021, specializing in Pharmacognosy with a focus on ethnopharmacology. Prior to this, he obtained a Diplôme d’Études Approfondies in Pharmacognosy from UNILU in 2016. His foundational education includes a Diplôme de Pharmacie d’Industrie et Analyse de Médicaments from UNILU, completed in 2012, and a Diplôme d’Études Générales en Sciences Pharmaceutiques from the University of Kinshasa (UNIKIN) in 2006. His academic journey demonstrates a strong commitment to advancing knowledge in pharmaceutical sciences, particularly in the areas of pharmacognosy and ethnopharmacology.

Professional Experience

Dr. Bashige Chiribagula Valentin has an extensive and diverse professional background in the field of pharmacognosy and ethnopharmacology. He has served as a Professor at the University of Lubumbashi since 2022, where he also holds positions as President of juries and Secretary of the Department of Pharmacology. His career at the university began as an Assistant in 2013, progressing to a Chief of Works and Specialist in Pharmacognosy. In addition to his academic roles, Dr. Chiribagula has been actively involved in the pharmaceutical industry as a Quality Control Manager at PROMED Lubumbashi. His research focuses on ethnopharmacology, medicinal chemistry, and quality control of medicinal plants, contributing significantly to the development of traditional medicine projects. Dr. Chiribagula’s career also includes roles in secondary education and civil society, showcasing his dedication to both education and community service.

Research Interest

Dr. Bashige Chiribagula Valentin’s research focuses on the ethnopharmacological and medicinal properties of plants, particularly in the context of traditional medicine. His work spans the study of plant-based remedies for various diseases, including malaria and diabetes, with a strong emphasis on the pharmacognosy of medicinal plants. Dr. Chiribagula’s research integrates ethnobotanical surveys, phytochemical analysis, and pharmacological testing to explore and validate the therapeutic potential of natural substances. His projects include the development of medicinal plants for wound healing, anti-malarial, anti-ulcer, and antibacterial applications. Additionally, he investigates the nutritional and medicinal benefits of indigenous fungi, fruits, and vegetables. His research aims to bridge traditional knowledge with modern scientific validation, contributing to the development of effective, natural therapeutic agents and enhancing the quality of life in the Democratic Republic of Congo.

Research Skills

Dr. Bashige Chiribagula Valentin demonstrates a robust set of research skills essential for advancing his field of study. His expertise spans ethnopharmacology, medicinal chemistry, and quality control, with a strong emphasis on the pharmacognostic and phytochemical evaluation of medicinal plants. Dr. Chiribagula excels in employing various analytical techniques, including chromatography (TLC, Flash, HPLC), spectral analysis (MS), and microbiological assays (antimicrobial testing, antioxidant assays). His proficiency in using statistical software such as SPSS and GraphPad supports his rigorous data analysis. Additionally, he has a solid background in experimental design and execution, demonstrated by his work on traditional medicine and natural product research. His ability to integrate traditional knowledge with scientific methodologies underscores his contributions to the development of novel therapeutic agents and quality control measures in pharmaceuticals. Dr. Chiribagula’s comprehensive approach and methodological skills are integral to his research successes.

Awards and Recognition

Dr. Bashige Chiribagula Valentin has garnered significant recognition for his contributions to pharmacognosy and ethnopharmacology. He was honored as the “Major de Promotion” in 2012 and achieved notable accolades in 2019, securing first place at the MT180 regional AUF competition and second place at the national MT180 competition. His scholarly excellence is highlighted by his award-winning research on ethnobotanical studies and medicinal plants, which has been recognized in several prestigious journals. Dr. Chiribagula’s impactful work in the development of medicinal plant-based treatments, including those for malaria and wound healing, has further solidified his reputation in the scientific community. These awards underscore his dedication to advancing knowledge in pharmaceutical sciences and his commitment to improving public health through innovative research.

Conclusion

Bashige Chiribagula Valentin is a strong candidate for the Research for Best Researcher Award due to his substantial contributions to ethnopharmacology, his significant publications, and his active role in academia and the pharmaceutical industry. His expertise in traditional medicine and his impactful research on medicinal plants, coupled with his notable awards and professional experience, underline his qualifications for the award.

Publications Top Notes

  • Ethnomedical Knowledge of Plants Used in Nonconventional Medicine for Wound Healing in Lubumbashi, Haut‐Katanga Province, DR Congo
    • Authors: Bashige Chiribagula Valentin
    • Year: 2024
  • Ethnomedicinal Knowledge of Plants Used in Nonconventional Medicine in the Management of Diabetes Mellitus in Kinshasa (Democratic Republic of the Congo)
    • Authors: Bashige Chiribagula Valentin
    • Year: 2023
  • Ethnobotanical study of plants used by traditional healers in Lubumbashi (Democratic Republic of Congo) in the management of typhoid fever
    • Authors: Bashige Chiribagula Valentin
    • Year: 2022
  • Activité antioxydante de 53 plantes réputées antimalariques en République Démocratique du Congo
    • Authors: Bashige Chiribagula Valentin
    • Year: 2021
  • In vitro antioxidant activity and in vivo aphrodisiac activity in male Cavia porcellus of Albizia adianthifolia (Schum.) W. Wight and Pericopsis angolensis (Baker) Meeuwen
    • Authors: Bashige Chiribagula Valentin
    • Year: 2021
  • Knowledge, attitudes and practices among the population, towards COVID-19 in the Lubumbashi city (DR Congo): An online cross-sectional survey
    • Authors: Bashige Chiribagula Valentin
    • Year: 2021
  • Mineral elements analysis and total flavonoids content in the fresh leaves from two varieties of Hibiscus sabdariffa L. consumed as vegetable in Lubumbashi (DR Congo)
    • Authors: Bashige Chiribagula Valentin
    • Year: 2021
  • Antimicrobial, antioxidant activities and toxicity on Cavia porcellus of Dialium angolense Welw. Ex Oliv, a traditional medicinal plant from Bagira in Eastern of DR Congo
    • Authors: Bashige Chiribagula Valentin
    • Year: 2020
  • Ethnobotanical study of medicinal plants used in the treatment of sexual dysfunctions in traditional medicine in Kampemba-Lubumbashi, DR Congo
    • Authors: Bashige Chiribagula Valentin
    • Year: 2020
  • Antiplasmodial, antioxidant and toxicological study of leaves extracts of Dalbergia katangensis Lecheneaud (Fabaceae) from Eastern DR Congo
    • Authors: Bashige Chiribagula Valentin
    • Year: 2020